<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02830399</url>
  </required_header>
  <id_info>
    <org_study_id>2015-A01810-49</org_study_id>
    <nct_id>NCT02830399</nct_id>
  </id_info>
  <brief_title>Clinical Trial on Efficacy of rTMS to Improve ECT in Treatment-Resistant Depression</brief_title>
  <acronym>STIMAGNECT</acronym>
  <official_title>Clinical Trial on Efficacy of Repeated Transcranial Magnetic Stimulation (rTMS) to Improve Electroconvulsive Therapy (ECT) in Treatment-Resistant Depression (TRD): STIMAGNECT Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier du Rouvray</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier Henri Laborit</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier du Rouvray</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It's a prospective, multicentric, randomized, controlled study concerning 84 patients with
      treatment-resistant depression (TRD). The aim of the study is to evaluate the augmentation of
      Electroconvulsive therapy (ECT) by repeated Transcranial Magnetic Stimulation (rTMS). The
      primary outcome will be the depressive symptoms intensity measured with the Hamilton Rating
      Scale For Depression (HAMD-21 items) after 5 ECT. The secondary outcome is to evaluate the
      safety and most particularly the cognitive effects of this association.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Included patients are adults, aged between 18 and 70 years, with major depression (Hamilton
      Rating scale for Depression, HAMD ≥ 15). Patients don't have any experience concerning
      repeated Transcranial Magnetic Stimulation (rTMS).

      Patients with treatment-resistant depression (TRD) were assigned to two treatment groups in
      addition to their current pharmacotherapy regimen : one group received 5 active-rTMS before
      Electroconvulsive therapy (ECT) and the other one received sham-rTMS before ECT. The
      depressive symptoms and the cognitive functions are evaluated before rTMS, after 5 rTMS and
      after 5 ECT.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Relative improvement of the Hamilton Rating Scale for Depression 21-items score</measure>
    <time_frame>Relative improvement of the Hamilton Rating Scale for Depression score between the inclusion and 19 days after the inclusion</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>active rTMS-ECT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>5 active high frequency rTMS before 5 bilateral ECT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham rTMS-ECT</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>5 sham rTMS before 5 bilateral ECT</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>active rTMS-ECT</intervention_name>
    <description>5 High Frequency (20Hz) rTMS (applicated on the left prefrontal dorsolateral cortex) before 5 bilateral ECT</description>
    <arm_group_label>active rTMS-ECT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham rTMS-ECT</intervention_name>
    <description>5 sham rTMS (applicated on the left prefrontal dorsolateral cortex) before 5 bilateral ECT</description>
    <arm_group_label>sham rTMS-ECT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Major Depressive Disorder (HAMD≥15)

          -  Level of resistance ≥ 3 (Thase and Rush)

          -  Participants who gave their informed, written consent

        Exclusion Criteria:

          -  Contraindication of Electroconvulsive therapy (ECT), repeated Transcranial Magnetic
             Stimulation (rTMS), Magnetic Resonance Imaging (MRI), anesthesia

          -  History of epilepsy; severe neurological or systemic disorder that could significantly
             affect cognition

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Maud Rothärmel, MD</last_name>
    <phone>00 33 2 32 95 10 31</phone>
    <email>maud.rotharmel@ch-lerouvray.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Olivier Guillin, MD.PhD</last_name>
    <email>olivier.guillin@ch-lerouvray.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Esquirol- CHU de Caen</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clément Nathou, MD.PhD</last_name>
      <email>nathou-c@chu-caen.fr</email>
    </contact>
    <contact_backup>
      <last_name>Sonia Dollfus, MD.PhD</last_name>
      <email>dollfus-s@chu-caen.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Laborit</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nemat Jaafari, MD.PhD</last_name>
      <email>nemat.jaafari@ch-poitiers.fr</email>
    </contact>
    <contact_backup>
      <last_name>Joyce Dohou</last_name>
      <email>aya-joyce.dohou@ch-poitiers.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier du Rouvray</name>
      <address>
        <city>Sotteville-lès-Rouen</city>
        <zip>76300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maud Rothärmel, MD</last_name>
      <email>maud.rotharmel@ch-lerouvray.fr</email>
    </contact>
    <contact_backup>
      <last_name>Olivier Guillin, MD.PhD</last_name>
      <email>olivier.guillin@ch-lerouvray.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 8, 2016</study_first_submitted>
  <study_first_submitted_qc>July 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 12, 2016</study_first_posted>
  <last_update_submitted>November 28, 2016</last_update_submitted>
  <last_update_submitted_qc>November 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier du Rouvray</investigator_affiliation>
    <investigator_full_name>Maud Rothärmel</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>treatment-resistant-depression</keyword>
  <keyword>rTMS</keyword>
  <keyword>ECT</keyword>
  <keyword>Augmentation strategy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
    <mesh_term>Depressive Disorder, Treatment-Resistant</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

